Table 1.

Surface and intracellular characterization of leukocytes day 12 in blood of TMZ IP- versus TMZ IC-treated mice (median values, n = 6/group)

Cell type	Treatment
	TMZ IP	TMZ IC	p a
CD45 count	4,521	21,918	0.0043**
F4/80 count	887	1,747	0.0087**
Ly6G count	467	1,728	0.0152*
CD11bGr1 count	1,315	3,158	0.0152*
CD4CD3 count	5,335	7,961	0.1320 NS
CD8CD3 count	2,157	4,452	0.0260*
Ki67/CD8 %	3.65	4.30	0.0411*
FoxP3CD25/CD4 %	6.90	5.35	0.1320 NS

^aStatistical differences using nonparametric Mann–Whitney U test between: TMZ IP versus TMZ IC. All p-values in bold represent significant differences between treatments